Last $3.50 USD
Change Today -0.06 / -1.69%
Volume 886.9K
PGNX On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark R. Baker J.D.

Chief Executive Officer, Director, Member of Science & Technology Committee and Member of Strategy & External Technology Subcommittee, Progenics Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 3 different organizations across 2 different industries.

See Board Relationships
58$1,377,606
As of Fiscal Year 2012

Background*

Mr. Mark R. Baker, J.D., has been the Chief Executive Officer of Progenics Pharmaceuticals, Inc. since March 2011 and served as its President from September 2009 to March 3, 2011. Mr. Baker served as a Secretary and General Counsel of Progenics Pharmaceuticals, Inc. since June 20, 2005 and served as its Executive Vice President-Corporate from 2008 to 2009. He served as Senior Vice President of Progenics Pharmaceuticals Inc., since June 20, 2005. He served as Chief Legal ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-789-2800
Fax: 914-789-2817

Board Members Memberships*

Director
Director
1999-Present
Chairman of the Board, Member of Executive Committee and Member of Compensation Committee
1999-Present
Non-Executive Chairman of the Board, Chief Legal Officer of Contigroup and Senior Vice President of Contigroup
2009-Present
Chief Executive Officer, Director, Member of Science & Technology Committee and Member of Strategy & External Technology Subcommittee

Education*

JD
School Of Law, Columbia University
BA
Columbia Business School

Other Affiliations*

Annual Compensation*

Salary$517,500
Bonus$155,250
Total Annual Compensation$672,750

Stock Options*

All Other Compensation$15,612
Exercisable Options556,041
Unexercisable Options300,000
Total Number of Options955,000

Total Compensation*

Total Annual Cash Compensation$688,362
Total Short Term Compensation$672,750
Other Long Term Compensation$15,612
Total Calculated Compensation$1,377,606
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $3.50 USD -0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
Cell Therapeutics, Inc.
$1.3M
James M. Gower Chairman, Chief Executive Officer and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$695.1K
Aijaz Tobaccowalla Managing Director, Additional Non-Executive Director, Member of Share Transfer Committee, Member of Audit Committee and Member of Shareholders' / Investors' Grievance Committee
Wyeth Limited
--
Peter S. Greenleaf Chief Executive Officer and Director
Sucampo Pharmaceuticals, Inc.
--
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.